Patients' clinicopathological and operative characteristics
| Characteristics | ERAS | CM | P value |
| (n=45) | (n=45) | ||
| N (%) | N (%) | ||
| Age (years) | 0.254 | ||
| Median | 53 | 58 | |
| Range | 20–81 | 19–75 | |
| BMI (kg/m2) | 0.516 | ||
| Median | 24.97 | 23.96 | |
| Range | 17.02–33.78 | 16.8–33 | |
| ASA score | 0.799 | ||
| 1–2 | 37 (82.2) | 34 (75.6) | |
| ≥3 | 8 (17.8) | 9 (20) | |
| Unknown | 0 | 2 (4.4) | |
| ECOG performance status (n (%)) | 0.598 | ||
| ECOG 0–1 | 37 (82.2) | 35 (77.8) | |
| ECOG ≥2 | 8 (17.8) | 10 (22.2) | |
| Co-morbidities (n (%)) | 0.793 | ||
| Diabetes Mellitus(DM) | 8 (17.8) | 13 (28.9) | |
| Hypertension | 12 (26.7) | 16 (35.6) | |
| Asthma/Chronic obstructive Pulmonary Disease(COPD) (n (%)) | 5 (11.1) | 4 (8.9) | |
| Coronary artery disease(CAD) | 1 (2.2) | 2 (4.4) | |
| History of malignancy | 3 (6.7) | 5 (11.1) | |
| Hyperlipidemia and endocrine | 11 (24.4) | 10 (22.2) | |
| Mental illness | 0 | 2 (4.4) | |
| History of vascular disease | 1 (2.2) | 2 (4.4) | |
| Stage (n (%)) | 0.83 | ||
| IIB | 2 (4.4) | 4 (8.9) | |
| III | 37 (82.2) | 36 (80) | |
| IV | 3 (6.7) | 2 (4.4) | |
| Relapse | 3 (6.7) | 3 (6.7) | |
| Histology (n (%)) | 0.645 | ||
| Epithelial | 43 (95.6) | 42 (93.3) | |
| Serous | 30 (69.8) | 28 (66.7) | |
| Non-serous | 13 (30.2) | 14 (33.3) | |
| Non-epithelial | 2 (4.4) | 3 (6.7) | |
| Surgery timing (n (%)) | 1 | ||
| Primary debulking surgery | 23 (51.1) | 23 (51.1) | |
| Interval debulking surgery | 19 (42.2) | 19 (42.2) | |
| Surgery for relapse | 3 (6.7) | 3 (6.7) | |
| Procedure (n (%)) | 0.396 | ||
| Staging procedure | 23 (51.1) | 27 (60) | |
| Complex cytoreductive procedure | 22 (48.9) | 18 (40) | |
| Operative time (min) | 229.30±73.81 | 219.10±76.66 | 0.522 |
| Staging procedure | 204.40±58.00 | 181.10±68.84 | |
| Complex cytoreductive procedure | 265.20±79.02 | 276.10±60.23 | |
| Estimated blood loss (mL) | 348.90±165.36 | 360.00±194.99 | 0.772 |
ASA, American Anesthesiologists Association; BMI, body mass index; CM, conventional management; COPD, chronic obstructive pulmonary disease; ECOG, Eastern Cooperative Oncoloy Group; ERAS, enhanced recovery after surgery.